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What is already known about this topic?  46 
• Diagnosing lower limb cellulitis on first presentation is challenging.  47 
• Approximately one in three patients admitted from the emergency department with 48 
suspected lower limb cellulitis do not have cellulitis and are given another diagnosis on 49 
discharge. These patients consequently have potentially avoidable hospital admission and 50 
antibiotic prescribing.  51 
• There are no diagnostic criteria available for lower limb cellulitis in the UK.  52 
 53 
 54 
What does this study add? 55 
• This systematic review has identified a key research gap in the diagnosis of lower limb 56 
cellulitis. 57 
• There is a current lack of robustly developed and validated diagnostic criteria or tools for 58 
use in clinical practice.  59 
 60 
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Abstract  77 
 78 
Background: Cellulitis can be a difficult diagnosis to make. 31% of patients admitted from the 79 
emergency department with suspected lower limb cellulitis are misdiagnoses, with incorrect 80 
treatment potentially resulting in avoidable hospital admission and antibiotic prescribing.  81 
Objective: We sought to identify diagnostic criteria or tools that have been developed for lower 82 
limb cellulitis.  83 
Methods: We conducted a systematic review using Ovid MEDLINE and Embase databases in 84 
May 2018, with the aim of describing diagnostic criteria and tools developed for lower limb 85 
cellulitis, and assessing the quality of the studies identified, using the QUADAS-2 tool. We 86 
included all types of study describing diagnostic criteria or tools. 87 
Results: Eight observational studies were included. Five studies examined biochemical markers, 88 
two studies assessed imaging and one study developed a diagnostic decision model. All eight 89 
studies were high risk in at least one domain for bias.  90 
Limitations: The quantity and quality of available data was low. Results could not be pooled due 91 
to the heterogeneity in findings. 92 
Conclusion: There is a lack of high quality publications describing criteria or tools for diagnosing 93 
lower limb cellulitis. Future studies using prospective designs and validated in both primary and 94 
secondary care settings are needed.  95 
 96 
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Introduction  99 
Cellulitis is an acute bacterial infection of the dermis and associated subcutaneous tissue, with 100 
60% of cases affecting the lower limb.1 Erysipelas is a form of cellulitis that presents with more 101 
marked superficial inflammation.2 102 
The diagnosis of cellulitis can be challenging, with 31% of presentations of suspected lower limb 103 
cellulitis in the emergency department (ED) subsequently given another diagnosis instead of 104 
cellulitis.3  Routine biochemical and haematology blood tests and blood cultures are not specific 105 
for cellulitis.4 This results in avoidable hospital admissions and unnecessary antibiotic 106 
prescribing.5 Definitive diagnostic criteria would potentially improve clinical care and also improve 107 
the validity of clinical research on cellulitis by ensuring appropriate case definition,6 but there are 108 
no agreed diagnostic criteria for cellulitis. 109 
Cellulitis cases commonly present to primary care services or the ED.7 A recent UK cellulitis 110 
research priority setting partnership ranked questions on 'diagnostic criteria' as important for 111 
future cellulitis research.8 112 
The aim of this systematic review was to identify and critically appraise the quality of studies that 113 
have developed or validated diagnostic criteria or tools for lower limb cellulitis.  114 
We define diagnostic criteria or tools as: including a minimum of one variable that has been tested 115 
against at least one clinical feature. ‘Cellulitis’ in this paper refers to lower limb cellulitis only. 116 
Lower limb erysipelas is included as it is clinically indistinguishable from cellulitis.  117 
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A preliminary search found no previous systematic reviews looking at the development or 118 
validation of cellulitis diagnostic criteria or tools for cellulitis.  119 
 120 
 121 
Methods  122 
Protocol and registration  123 
This systematic review was conducted and reported in accordance with the Preferred Reporting 124 
Items for Systematic Reviews and Meta-analyses (PRISMA) statement,9 with additional reference 125 
to the Cochrane Handbook for Diagnostic Test Accuracy Reviews.10 The protocol was registered 126 
with PROSPERO (http://www.crd.york.ac.uk/PROSPERO, record CRD42017080466, November 127 
2017).  128 
Objectives 129 
The primary objective for this review was to identify and describe diagnostic criteria and tools that 130 
have been developed for lower limb cellulitis. The secondary objective was to assess the quality 131 
of the studies where diagnostic criteria or tools were developed.  132 
Eligibility criteria  133 
Studies including patients with lower limb cellulitis or erysipelas in primary and secondary care, 134 
where diagnostic criteria or tools were used for diagnosis were included. 135 
Inclusion criteria 136 
All study types, all languages, any age, gender and ethnicity, patients with lower limb cellulitis or 137 
erysipelas , diagnostic criteria or tools. 138 
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Exclusion criteria  139 
Animal studies, laboratory in vitro studies, literature and systematic review articles, expert 140 
opinions, conference abstracts, only including patients with non-lower limb cellulitis, if the site of 141 
cellulitis or erysipelas is not clear, if data from lower limb cellulitis or erysipelas cannot be 142 
separated, tools to determine etiology, case series <20 patients, <10 lower limb cellulitis or 143 
erysipelas patients included.  144 
Database and searches 145 
The following databases were searched on 25 October 2017: Ovid MEDLINE In-Process & Non-146 
Indexed Citations and Ovid MEDLINE 1946 to present, Ovid Embase (1980 to 2017), Cochrane 147 
Library and Web of Science Core Collection. An updated search on 22 May 2018 was also 148 
undertaken in all the databases to ensure that the results were up-to-date.  149 
Search strategies for these databases were developed with an information specialist (DG) and in 150 
consultation with a cellulitis expert (NJL). Concepts were developed: ‘cellulitis’, ‘diagnosis’ and 151 
‘criteria’, with controlled vocabulary (MeSH term and Emtree) and free text headings (Table 1). 152 
NICE Evidence was also searched using the term ‘cellulitis’.  153 
For grey literature, the first 100 articles on Google Scholar were included using the search 154 
‘diagnostic criteria for cellulitis’, sorted by relevance.  155 
The reference lists of all studies selected for critical appraisal were screened for additional 156 
studies.  157 
Study selection and data extraction  158 
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Following the searches, all citations were uploaded into Covidence (2018): a systematic review 159 
management software,11 with duplicates removed by one reviewer (MP). Title and abstract 160 
screening, full text screening and data extraction were conducted by two independent reviewers 161 
(MP and SL/RKA) using pre-defined templates. Any disagreements that arose between any 162 
reviewers were resolved through discussion, or with a third independent reviewer (KST, JK or 163 
NJL). Data items sought at the data extraction stage included study aim, type, population, criteria, 164 
funding, sample size, index test, reference test and key findings.  165 
 166 
Evidence synthesis and risk of bias assessment  167 
All included studies were described in a narrative synthesis. To assess the methodological quality, 168 
all studies were assessed using signalling questions in the QUADAS-2 tool 12 by two reviewers 169 
(MP and RKA), with disagreements resolved with a third reviewer (SL or EBT).  If the information 170 
was not clearly provided in the study, then the reviewers assessed the signalling question as 171 
‘unclear’.  172 
For each domain, studies were judged as ‘low risk’ if all signalling questions were ‘yes’; ‘high risk’ 173 
if at least one signalling question was ‘no’; or ‘unclear’ if in between 12.  174 
 175 
 176 
 177 
 178 
 179 
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Results  184 
Study selection 185 
The PRISMA flow diagram shows the result of the complete search (Figure 1). A total of 98 papers 186 
were included for full text screening.5, 13-109 Of these, 90 papers were subsequently excluded 5, 21-187 
109: including 20 studies that did not specify the site of cellulitis 5,37, 45, 46, 49, 50, 52, 63, 69,70, 72, 78, 81, 91, 93, 188 
95, 97, 100, 102, 109 and eight studies that did not separate the results of lower limb cellulitis from other 189 
sites.26,29,55,87,90,98,99,107 Eight studies were included for data extraction.13-20  190 
Study characteristics               191 
Characteristics of all eight included studies are summarised in Table 2. Raff et al explored lower 192 
limb cellulitis as the main pathology.18 Seven studies included lower limb cellulitis patients as a 193 
comparison group, where cellulitis and other diagnoses were compared.13-17, 19-20 194 
Six studies were case control studies,13-16, 19-20 with one cohort study 17 and one cross sectional 195 
study.18 The most common setting, in three studies, was the ED.17-20 The studies were conducted 196 
in six different countries. Kato et al did not include exclusion criteria.14  197 
Reference tests 198 
9 
 
Page 9 
 
The reference test for cellulitis was a clinical diagnosis in seven studies,14-20 with a bone scan 199 
used by Fleischer et al.13 However, only Rabuka et al clearly stated which specialty made the 200 
cellulitis diagnosis.17 Two studies followed up patients for up to thirty days to determine the final 201 
diagnosis.18,19  202 
 203 
 204 
 205 
Index tests 206 
Studies where cellulitis was the main pathology 207 
Predictive score                                                                                                                                                                                                                                          208 
In a study to compare cellulitis from pseudocellulitis, Raff et al developed an ALT-70 score out of 209 
7: asymmetry (unilateral involvement, 3 points), leukocytosis (white blood cell count ≥10,000/uL, 210 
1 point), tachycardia (heart rate ≥90 bpm, 1 point) and age ≥70 years (2 points).18 An ALT-70 211 
score below 3 had a >83.3% likelihood of pseudocellulitis: an alternative diagnosis to cellulitis, 212 
and above 4 had a >82.2% likelihood of cellulitis.18  213 
Studies where cellulitis was used as a comparator  214 
Clinical features 215 
One study comparing cellulitis and osteomyelitis amongst diabetic patient found that a 216 
temperature higher than 37.2°C was predictive of osteomyelitis,13 however Malabu et al showed 217 
no significant differences in clinical parameters between these groups.15  218 
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Rabuka et al showed that distinct margins of erythema were seen in 6 (8%) cellulitis patients vs 219 
0 (0%) in deep vein thrombosis (DVT) (p=0.008).17 However, when comparing erysipelas and 220 
DVT, Rast et al found no significant differences between any physical signs.19  221 
Biochemical and haematological tests 222 
In a study comparing cellulitis with acute gout, delta neutrophil index (DNI: immature granulocyte 223 
count) > 1.7% was the only independent factor for predicting cellulitis (P = 0.002), compared to 224 
white blood cell count (WBC) (p=0.41), C-reactive protein (CRP) (p=0.277) and procalcitonin 225 
(PCT) (p=0.122).16 Creatine kinase (CK) was significantly higher in all cases of necrotising fasciitis 226 
(NF) compared to cellulitis.14   227 
Malabu et al found that in diabetic patients, haemoglobin (p<0.0001) and haematocrit (p<0.0001) 228 
were higher in cellulitis patients than in osteomyelitis.15 However, erythrocyte sedimentation rate 229 
(ESR) (p <0.0001),13, 15 CRP (p <0.0001),13 platelet count (p<0.01),15 WBC (p<0.05) 15 and red 230 
cell width (RDW) (p<0.05) 15 were higher in osteomyelitis than in patients with cellulitis.15 231 
One study compared PCT concentrations in patients with erysipelas and (DVT).19  Patients with 232 
erysipelas had significantly higher concentrations of PCT (p = 0.001). At a PCT threshold of > 233 
0.25 ug/L, the specificity and positive predictive value for erysipelas was 100%. No significant 234 
differences were seen between the two groups with regard to CRP concentrations (p = 0.20) and 235 
WBC counts (p = 0.14).19    236 
In contrast, Rabuka et al found a raised WBC in 21.3% of cellulitis patients versus 50% of DVT 237 
patients (p=0.038).17 This study also found that CK was higher in the cellulitis group compared to 238 
DVT.17  239 
Imaging 240 
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In a study comparing cellulitis with lymphoedema using computed tomography (CT) scanning, 241 
Shin et al found specific features that were more frequently associated with cellulitis.20 These 242 
were fluid collection (P = 0.009); fascial enhancement (P = 0.043); inguinal lymph node 243 
enlargement at the affected side (P<0.001) and inguinal lymph node medullary fat obliteration 244 
(P<0.001).  245 
Rabuka et al looked at ultrasound imaging in patients with a presentation suggestive of cellulitis, 246 
with 72 (80%) patients diagnosed with cellulitis after having a negative duplex scan.17  247 
 248 
Methodological quality  249 
Risk of bias 250 
The risk of bias for patient selection was high for all eight studies: six used a case control method 251 
13-16, 19-20 and the exclusion criteria were not deemed appropriate in two studies as they excluded 252 
patients who are more difficult to diagnose (Table 3 and Figure 2).17-18 Shin et al had low risk of 253 
bias for the index test, by including a pre-specified threshold,20 whilst the other seven studies did 254 
not.13-19 Rabuka et al was high risk for the reference standard as some patients received the 255 
reference test after the index test,17 increasing observer bias, whilst the risk was unclear in the 256 
remaining seven studies as it is not possible to determine how accurate the diagnosis of cellulitis 257 
was. The flow of timing was unclear in seven studies,14-20 as it was not stated if all the patients 258 
received the same reference standard test. Fleischer et al was high risk for the flow of timing as 259 
not all the patients were analysed.13  260 
Concerns regarding applicability  261 
For patient selection and reference standard applicability, all eight studies included patients who 262 
had already been diagnosed with cellulitis and we cannot definitely state that the correct diagnosis 263 
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had been made. However, five studies were high risk for patient selection as they either included 264 
a rare differential diagnoses for cellulitis: osteomyelitis and NF 13-15 or only included patients with 265 
an initial suspected DVT.17, 20 The index test in four studies were high risk: two studies only 266 
included investigations for diabetic foot ulcers 13,15 and two studies included imaging for suspected 267 
DVT.17,20  268 
Excluded studies  269 
Of the excluded studies, twenty did not specify the site of cellulitis. Of these, David et al developed 270 
a visually-based computerized diagnostic decision support system.5 Pallin et al looked at PCT 271 
and HLA-DQA1 expression,81 with Kini et al looking at ESR 52 and three examining the Laboratory 272 
Risk Indicator for Necrotizing Fasciitis (LRINEC) score.63, 78,109 Six studies explored radio 273 
nucleotide or bone imaging,37,45,69,70,93,102 five looked at magnetic resonance imaging (MRI) 274 
49,50,91,95,97 and two considered ultrasound imaging in the paediatric setting.46,72 Smirnova et al 275 
looked at antibodies in erysipelas.100  276 
Eight studies did not present the results of lower limb cellulitis separately. Of these, Rahmouni et 277 
al examined MRI in cellulitis 90 and Chao et al utilised ultrasound imaging for soft tissue infections 278 
in the paediatric population.29 Bonnetblanc et al looked at a modification of the LRINEC score,26 279 
two studies focused on multiple laboratory and clinical markers 98,99 and Radkevich et al 280 
investigated coagulable factors.87  Wang et al discussed tissue oxygen saturation monitoring 107 281 
with Ko et al looking at thermal imaging camera.54,55  282 
 283 
 284 
 285 
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Discussion  294 
Main findings 295 
We found no robustly developed and validated diagnostic tools or criteria for lower limb cellulitis.   296 
A variety of potential tools have been explored so far: biochemical tests, imaging, predictive 297 
scoring and clinical features. However, in seven of the eight included studies, cellulitis was not 298 
the main pathology of interest and used as a comparator. Three studies compared cellulitis with 299 
rare differential diagnoses such as osteomyelitis, which provide limited clinical applicability. This 300 
diversity in tools explored emphasises the difficulty in making a correct a correct diagnosis on first 301 
presentation.  302 
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All eight included studies identified in this review were observational studies.16-19 The sample sizes 303 
were small, with only two studies including more than 100 patients with cellulitis.16, 18 No criteria 304 
or tools have been validated subsequently in a large, prospective study. 305 
Despite cellulitis being a common presentation in the community, all the tools identified to date 306 
have been developed and tested in secondary care, with limited evidence of validity or 307 
applicability in community settings. No study stated that the gold standard reference for clinical 308 
diagnosis was a board certified dermatologist or other specialist with cellulitis expertise.  Only one 309 
study clearly stated who made the cellulitis diagnosis.17 310 
Relevance to clinical practice  311 
All the tools developed to date can be accessed by secondary care, are already available, and 312 
with the exception of CT imaging, are inexpensive. The severity of cellulitis is likely to be worse 313 
in secondary care. However, none of these tools can be used until they are validated in higher 314 
quality studies.  315 
Three studies included rare pathologies that provide very limited clinical relevance, as they are 316 
not common misdiagnoses of cellulitis.110 Blood tests need to be interpreted with caution, as ESR, 317 
CRP and WCC are non-discriminatory markers, but can be used to guide a clinician when the 318 
differential diagnoses have been narrowed. High levels of these markers can also help point 319 
towards rarer pathologies such as NF. 320 
Only one study included paediatric patients,20 therefore findings cannot be translated to this under 321 
researched population.  322 
Strengths and limitations of this review  323 
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This is the first systematic review identifying diagnostic criteria or tools that have been developed 324 
for lower limb cellulitis. The key strengths of this review are the comprehensive search strategy 325 
used, supported by an experienced information specialist. The focus of this review was lower limb 326 
cellulitis and therefore if the site of cellulitis was not specified or a study did not present the results 327 
of lower limb cellulitis separately, then they were excluded.  328 
The limitations of this review stem from the number and quality of the studies included. Data could 329 
not be pooled as the index tests were not comparable. Also, twenty-eight papers were excluded 330 
as the site of cellulitis was not specified or the results of lower limb cellulitis were not separated. 331 
These papers did include diagnostic criteria or tools that need to be further evaluated. Due to time 332 
constraints, only the first 100 results on Google Scholar were included. 333 
 334 
 335 
 336 
 337 
Conclusion  338 
This systematic review has identified an important research gap in the diagnosis of lower limb 339 
cellulitis. There is currently insufficient evidence available to support the validity of any diagnostic 340 
criteria or tools that have been developed for lower limb cellulitis. As such, their utility for clinical 341 
practice or research remains unclear.  342 
Future studies should employ prospective designs, using diagnosis by board certified specialists 343 
with cellulitis expertise as the reference diagnostic standard and be validated in both primary and 344 
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secondary care settings. To better understand what should be included in diagnostic criteria or 345 
tools, qualitative research including input from a range of healthcare professionals and patients 346 
with experience of managing lower limb cellulitis could helpfully be undertaken.  347 
 348 
Acknowledgements 349 
We would like to thank Dr Esther Burden-Teh for independently reviewing the protocol internally 350 
and helping assess the methodological quality. We also thank Dr Yana Vinogradova for 351 
translating and full text screening the Russian transcripts.  352 
 353 
 354 
 355 
 356 
 357 
 358 
References 359 
1. Lazzarini L, Conti E, Tositti G et al. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary 360 
care hospital. J Infect 2005; 51(5):383-9. 361 
2. Morris AD. Cellulitis and erysipelas. BMJ Clin Evid 2008; 01:1708.  362 
3. Weng QY, Raff AB, Cohen JM et al. Costs and Consequences Associated With Misdiagnosed Lower Extremity 363 
Cellulitis. JAMA Dermatol 2017; 153(2):141–146.  364 
4. Raff AB, Kroshinsky D. Cellulitis: A Review. JAMA 2016; 316(3):325-337. 365 
5. David CV, Chira S, Eells SJ et al. Diagnostic accuracy in patients admitted to hospitals with cellulitis. Dermatol Online 366 
J 2011; 17(3):1.   367 
17 
 
Page 17 
 
6. Obaitan I, Dwyer R, Lipworth AD et al. Failure of antibiotics in cellulitis trials: a systematic review and meta-analysis. 368 
Am J Emerg Med 2016; 34(8):1645-52. 369 
7. Lee A, Levell N. Cellulitis: clinical review. GP online. 2016. Available from URL: http://www.gponline.com/cellulitis-370 
clinical-review/dermatology/article/1379850. 371 
8. Thomas KS, Brindle R, Chalmers JR et al. Identifying priority areas for research into the diagnosis, treatment and 372 
prevention of cellulitis (erysipelas): results of a James Lind Alliance Priority Setting Partnership. Br J Dermatol 2017; 373 
177:541-543.  374 
9. Moher D, Liberati A, Tetzlaff J et al. PRISMA Group. Preferred reporting items for systematic reviews and meta-375 
analyses: the PRISMA statement. PLoS Med 2009; 6:e1000097.  376 
10. Cochrane Collaboration Cochrane handbook for diagnostic test accuracy reviews.  Available from 377 
URL: http://methods.cochrane.org/sdt/handbook-dta-reviews.   378 
11. Covidence – better systematic review management. Available from URL: https://www.covidence.org/home. 379 
12. PF Whiting, AW Rutjes, ME Westwood et al. QUADAS-2: a revised tool for the quality assessment of diagnostic 380 
accuracy studies. Ann Intern Med 2011; 155 (8):529-536.  381 
13. Fleischer A, Didyk A, Woods J et al. Combined clinical and laboratory testing improves diagnostic accuracy for 382 
osteomyelitis in the diabetic foot. J Foot Ankle Surg 2009; 48:39-46. 383 
14. Kato, T.; Fujimoto, N.; Honda, S et al. Usefulness of serum procalcitonin for early discrimination between necrotizing 384 
fasciitis and cellulitis. Acta Derm Venereol 2017; 97(1):141-142. 385 
15. Malabu UH, Al-Rubeaan KA, Al-Derewish M. Diabetic foot osteomyelitis: usefulness of erythrocyte sedimentation rate 386 
in its diagnosis. West Afr J Med 2007; 26:113-6. 387 
16. Pyo JY, Ha YJ, Song JJ et al. Delta neutrophil index contributes to the differential diagnosis between acute gout attack 388 
and cellulitis within 24 hours after hospitalization. Rheumatology 2017; 56(5): 795-801. 389 
17. Rabuka CE, Azoulay LY, Kahn SR. Predictors of a positive duplex scan in patients with a clinical presentation 390 
compatible with deep vein thrombosis or cellulitis. Can J Infect Dis 2003; 14(4): 210-214. 391 
18. Raff AB, Weng QY, Cohen JM et al. A predictive model for diagnosis of lower extremity cellulitis: A cross-sectional 392 
study. J Am Acad Dermatol 2017; 76(4): 618-625. 393 
19. Rast AC, Knobel D, Faessler L et al. Use of procalcitonin, C-reactive protein and white blood cell count to distinguish 394 
between lower limb erysipelas and deep vein thrombosis in the emergency department: A prospective observational 395 
study. J Dermatol 2015; 42(8):778-785. 396 
20. Shin SU, Lee W, Park EA et al. Comparison of characteristic CT findings of lymphedema, cellulitis, and generalized 397 
edema in lower leg swelling. Int J Cardiovasc Imaging 2013; 29:135-43. 398 
18 
 
Page 18 
 
21. Bae KU, Kim SH, Oo JH et al. Comparison between 3-phase bone scan and MRI in diagnosis of osteomyelitis. J Nucl 399 
Med 2010; 51. 400 
22. Bailey EE. Diagnostic guidelines for cellulitis: Recommendations based on a retrospective analysis of cellulitis 401 
admissions to Massachusetts General Hospital. J Am Acad Dermatol 2011; 64 (2): AB12.  402 
23. Beltran J, Noto AM, McGhee RB. Infections of the musculoskeletal system: High-field-strength MR imaging. Radiology 403 
1987; 164: 449-54. 404 
24. Bernard P, Leonard G, Mounier, M et al. Sensitivity and specificity of detection of streptococcic antigens by latex-405 
agglutination on cutaneous biopsy in erysipelas, cellulitis and necrotizing fasciitis. Ann Dermatol Venereol 1987; 406 
114(3):469-469. 407 
25. Bernard P, Toty L, Mounier M. Early detection of streptococcal group antigens in skin samples by latex particle 408 
agglutination. Arch Dermatol 1987; 123(4):468-470 409 
26. Bonnetblanc JM, Bernard P, Dupuy, A. Acute red swollen legs. Ann Dermatol Venereol 2002; 129 (10): 2S170-2S175. 410 
27. Borschitz T, Schlicht S, Siegel E et al. Improvement of a Clinical Score for Necrotizing Fasciitis: 'Pain Out of Proportion' 411 
and High CRP Levels Aid the Diagnosis. Plos One 2015; 10:13. 412 
28. Cellulitis and Erysipelas. 2018. British Association of Dermatology.  413 
29. Chao H-C, Lin S-J, Huang Y-C et al. Sonographic evaluation of cellulitis in children. J Ultrasound Med 2000; 19:743-414 
9. 415 
30. Chebotarev VV, Schastnyi EI. Use of the passive hemagglutination reaction for the diagnosis of erysipelas. Lab Delo 416 
1970; 3:162-4. 417 
31. Chen YM, Chen HH, Chao WC et al. Non-invasive assessment of cellulitis from snapshot hyperspectral imaging - A 418 
primary study. Skin Res Technol 2018; 24:343-6. 419 
32. Defty CL, Goulding JMR, Ahmed I. Retrospective assessment of the diagnostic accuracy of an admitting diagnosis of 420 
cellulitis and appropriateness of antibiotic therapy. Br J Dermatol 2010; 163:67-68. 421 
33. Devillers A, Moisan A, Hennion F et al. Contribution of technetium-99m hexamethylpropylene amine oxime labelled 422 
leucocyte scintigraphy to the diagnosis of diabetic foot infection. Eur J Nucl Med Mol Imaging 1998; 25:132-8. 423 
34. Dobozy A, Schneider I, Hunyadi J et al. Leukocyte migration test in recurrent erysipelas. Acta Derm Venereol 1973; 424 
53(1):35-8. 425 
35. Dominguez-Gadea L, Martin-Curto LM, de la Calle H et al. Diabetic foot infections: scintigraphic evaluation with 99Tcm-426 
labelled anti-granulocyte antibodies. Nucl Med Commun 1993; 14: 212-8. 427 
36. Durham JR, Lukens ML, Campanini DS et al. Impact of magnetic resonance imaging on the management of diabetic 428 
foot infections. Am J Surg 1991; 162:150-4. 429 
37. Gilday DL, Paul DJ, Paterson J. Diagnosis of osteomyelitis in children by combined blood pool and bone imaging. 430 
Radiology 1975; 117:331-5. 431 
19 
 
Page 19 
 
38. Gottlieb M, Pandurangadu AV. What Is the Utility of Ultrasonography for the Identification of Skin and Soft Tissue 432 
Infections in the Emergency Department? Ann Emerg Med 2017; 70:580-2. 433 
39. Groshar D, Keren R, Gips S et al. Osteomyelitis and cellulitis. The value of the lateral view in Ga-67 scintigraphy. Clin 434 
Nucl Med 1984; 9(4):236-7. 435 
40. Ha DH, Kim TE. "early draining veins sign" on additional CT arteriography: For the differential diagnosis of soft tissue 436 
infection. Skeletal Radiology 2017; 46(9):1311. 437 
41. Hashefi M. Ultrasound in the diagnosis of noninflammatory musculoskeletal conditions. Ann N Y Acad Sci 2009; 1154: 438 
171-203. 439 
42. Hexsel DM, Abreu M, Rodrigues TC et al. Side-by-side comparison of areas with and without cellulite depressions 440 
using magnetic resonance imaging. Dermatol Surg 2009; 35:1471-7. 441 
43. Hopkins KL, Li KC, Bergman G. Gadolinium-DTPA-enhanced magnetic resonance imaging of musculoskeletal 442 
infectious processes. Skeletal Radiol 1995; 24:325-30. 443 
44. Horowitz JD, Durham JR, Nease DB et al. Prospective evaluation of magnetic resonance imaging in the management 444 
of acute diabetic foot infections. Ann Vasc Surg 1993; 7:44-50. 445 
45. Howie DW, Savage JP, Wilson TG et al. The technetium phosphate bone scan in the diagnosis of osteomyelitis in 446 
childhood. J Bone Joint Surg Am 1983; 65:431-7. 447 
46. Iverson K, Haritos D, Thomas R et al. The effect of bedside ultrasound on diagnosis and management of soft tissue 448 
infections in a pediatric ED. Am J Emerg Med 2012; 30(8):1347-51. 449 
47. Kadkina VV, Kravchenko IE, Aybatova GL et al. The Role of CYP1A1 Gene Polymorphism in Patients with Erysipelas. 450 
Bionanoscience 2017; 7:648-53. 451 
48. Kan JH, Hilmes MA, Martus JE et al. Value of MRI After Recent Diagnostic or Surgical Intervention in Children with 452 
Suspected Osteomyelitis. AJR Am J Roentgenol 2008; 191:1595-600. 453 
49. Kan JH, Young RS, Yu C et al. Clinical impact of gadolinium in the MRI diagnosis of musculoskeletal infection in 454 
children. Pediatr Radiol 2010; 40:1197-205. 455 
50. Kattapuram TM, Treat ME, Kattapuram SV. Magnetic resonance imaging of bone and soft tissue infections. Curr Clin 456 
Top Infect Dise 2001; 21:190-226. 457 
51. Khoury NJ, El Khoury GY. Imaging of musculoskeletal diseases. J Med Liban 2009; 57:26-46. 458 
52. Kini JR, Kavyashree, Datla SP et al. Erythrocyte sedimentation rate revisited: Evaluation of the clinical relevance of 459 
elevated erythrocyte sedimentation rate and its correlation with the final diagnosis. Res J Pharm Biol Chem Sci 2016; 460 
7:443-8. 461 
53. Klinker H, Langmann P, Gillitzer R. Skin efflorescences in infectious diseases. Part II: Skin efflorescences in bacterial 462 
diseases, dermatomycoses and epizooneses. [German]. Internist 2002; 43:259-78. 463 
54. Ko L, Raff AB, Garza-Mayers AC et al. Skin surface temperature detection with thermal imaging camera aids in cellulitis 464 
diagnosis. J Invest Dermatol 2017; 137(5 Supplement 1):S54. 465 
20 
 
Page 20 
 
55. Ko LN, Raff AB, Garza-Mayers AC et al. Skin Surface Temperatures Measured by Thermal Imaging Aid in the 466 
Diagnosis of Cellulitis. J Invest Dermatol 2018; 138:520-6. 467 
56. Ko NK, Garza-Mayers AC, St John J et al. Clinical Usefulness of Imaging and Blood Cultures in Cellulitis Evaluation. 468 
JAMA Intern Med 2018; 178(7): 994-996.  469 
57. Kriukova SA. [Neutrophil phosphatase activity in erysipelas]. Lab Delo 1979: 48-50. 470 
58. Kumar Nath A, Sethu AU. Use of ultrasound in osteomyelitis. Br J Radiol 1992; 65:649-52. 471 
59. Kurepa D, Galiczewski C, Civale A et al. Point-Of-Care Ultrasound as an Adjunct in the Diagnosis of Neonatal and 472 
Pediatric Superficial Soft Tissue Infection: A Report of Two Cases. Ostomy/wound manage 2017; 63:14-9. 473 
60. Lahoza-Perez MC, Martinez-Diez M, Saenz-Abad D et al. [Useful diagnostic tools for early recognition of necrotising 474 
soft tissue infections]. Semergen Sociedad Espanola de Medicina Rural y Generalista 2016; 42:e87-9. 475 
61. Lam SK, Wong HT. The lrinec (laboratory risk indicator for necrotizing fasciitis) score: A review on the tool for 476 
distinguishing necrotizing fasciitis from other soft tissue infections. Hong Kong J Emerg Me 2010; 17(4):419. 477 
62. Leppard BJ, Seal DV, Colman G et al. The value of bacteriology and serology in the diagnosis of cellulitis and 478 
erysipelas. Br J Dermatol 1985; 112(5):559-67. 479 
63. Liao CI, Lee YK, Su YC et al. Validation of the laboratory risk indicator for necrotizing fasciitis (LRINEC) score for early 480 
diagnosis of necrotizing fasciitis. Tzu Chi Medical Journal 2012; 24:73-6. 481 
64. Liles DK, Dall LH. Needle aspiration for diagnosis of cellulitis. Cutis 1985; 36(1):63-4. 482 
65. Lipsky BA, Kollef MH, Miller LG et al. Predicting Bacteremia among Patients Hospitalized for Skin and Skin-Structure 483 
Infections: Derivation and Validation of a Risk Score. Infect Control Hosp Epidemiol 2010; 31:828-37. 484 
66. Liu B, Servaes S, Zhuang H. Elevated soft tissue activity in early but not delayed phase of bone scan in Klippel-485 
Trenaunay Syndrome. Clin Nucl Med 2013; 24. 486 
67. Loh NN, Ch'en IY, Cheung LP et al. Deep fascial hyperintensity in soft-tissue abnormalities as revealed by T2-weighted 487 
MR imaging. AJR Am J Roentgenol 1997; 168:1301-4. 488 
68. Mahajan A, Tobase P, Phelps A et al. Radiologist-performed musculoskeletal ultrasound (MSKUS) for evaluation of 489 
joint and soft tissue pain episodes in patients with bleeding disorders. Blood 2015; 126(23):3266. 490 
69. Majd M, Frankel RS. Radionclide imaging in skeletal inflammatory and ischemic disease in children. AJR Am J 491 
Roentgenol 1976; 126:832-41. 492 
70. Majd M. Radionulide imaging in early detection of childhood osteomyelitis and its differentiation from cellulitis and bone 493 
infection. Ann Radiol 1977; 20:9-18. 494 
71. Marandian MH, Mortazavi H, Behvad A et al. [Bone scan in the diagnosis of infectious osteoarthritis (author's transl)]. 495 
Sem Hop 1980; 56:873-9. 496 
72. Marin JR, Dean AJ, Bilker WB et al. Emergency Ultrasound-assisted Examination of Skin and Soft Tissue Infections 497 
in the Pediatric Emergency Department. Acad Emerg Med 2013; 20(6):545-553. 498 
73. Markel A, Weich Y, Gaitini D. Doppler ultrasound in the diagnosis of venous thrombosis. Angiology 1995; 46:65-73. 499 
21 
 
Page 21 
 
74. Math KR, Berkowitz JL, Paget SA et al. Imaging of Musculoskeletal Infection. Rheum Dis Clin North Am 2016; 42:769-500 
84. 501 
75. Merzoug V, Kalifa G, Gendrel D. The role of scanning in children with infectious diseases. [German]. Medecine 502 
Therapeutique Pediatrie 2001; 4:291-8. 503 
76. Momeni MG, Borghei P, Tehranzadeh J. Enhanced MR imaging in musculoskeletal infection. Applied Radiology 2006; 504 
35:28-32. 505 
77. Narasimhan V, Ooi G, Weidlich S et al. Laboratory Risk Indicator for Necrotizing Fasciitis score for early diagnosis of 506 
necrotizing fasciitis in Darwin. ANZ J Surg 2018; 88:E45-E9. 507 
78. Neeki MM, Dong F, Au C et al. Evaluating the Laboratory Risk Indicator to Differentiate Cellulitis from Necrotizing 508 
Fasciitis in the Emergency Department. West J Emerg Med 2017; 18:684-9. 509 
79. Olivier C. Cellulitis in children. [French]. Arch Pediatr 2001; 8:465s-7s. 510 
80. Olivier P, Erika PD, Thibault D et al. Procalcitonin in necrotizing soft tissue infection: An interesting prognostic marker 511 
and a potentially useful marker to guide the antimicrobial therapy duration. Ann Intensive Care 2018; 8. 512 
81. Pallin DJ, Bry L, Dwyer RC et al. Toward an Objective Diagnostic Test for Bacterial Cellulitis. PLoS One 2016; 11(9):15. 513 
82. Papandreou I, Moschouris H, Papadopoulos G et al. Ultrasound and color doppler imaging in the evaluation of soft 514 
tissue lumps in infants and children. Acta Paediatr 2011; 100:52. 515 
83. Parish LC, Witkowski JA. Defining cellulitis. Skinmed 2007; 6(6):261-3. 516 
84. Petscavage-Thomas JM, Walker EA, Bernard SA et al. Imaging findings of adiposis dolorosa vs. massive localized 517 
lymphedema. Skeletal Radiol 2015; 44:839-47. 518 
85. Pretorius ES, Fishman EK. Helical CT of musculoskeletal infection. Crit Rev Diagn Imaging 2001; 42:259-305. 519 
86. Provan JL. Diagnosis of venous thrombosis. Geriatrics 1968; 23:136-43. 520 
87. Radkevich RA, Ryskind RR, Guseva TM. [Blood coagulation and anticoagulation systems in erysipelas]. Sovetskaia 521 
Meditsina 1973; 36:147. 522 
88. Raff A, Purschke M, Farinelli B et al. A comparison of two new techniques for bacterial collection in cellulitis. J Invest 523 
Dermatol 2016; 1:S48. 524 
89. Raff A, Weng Q, Vedak P et al. A predictive model for suspected lower limb cellulitis in the emergency department. J 525 
Invest Dermatol 2016; 1:S35.  526 
90. Rahmouni A, Chosidow O, Mathieu D et al. MR imaging in acute infectious cellulitis. Radiology 1994; 192(2):493-496. 527 
91. Revelon G, Rahmouni A, Jazaerli N et al. Acute swelling of the limbs: magnetic resonance pictorial review of fascial 528 
and muscle signal changes. Eur J Radiol 1999; 30(1):11-21. 529 
92. Rodriguez RM, Abdullah R, Miller R et al. A pilot study of cytokine levels and white blood cell counts in the diagnosis 530 
of necrotizing fasciitis. Am J Emerg Med 2006; 24:58-61. 531 
22 
 
Page 22 
 
93. Rosenthall L, Kloiber R, Damtew B et al. Sequential use of radiophosphate and radiogallium imaging in the differential 532 
diagnosis of bone, joint and soft tissue infection: quantitative analysis. Diagn Imaging 1982; 51:249-58. 533 
94. Rossi A, Iurassich S, Spena A et al. The usefulness of ultrasonography in the diagnosis of some skin and hypoderma 534 
diseases. [Italian]. Annali Italiani di Dermatologia Clinica e Sperimentale 1996; 50:57-61. 535 
95. Saiag P,  Le Breton C, Pavlovic M et al. Magnetic resonance imaging in adults presenting with severe acute infectious 536 
cellulitis. Arch Dermatol 1994; 130(9):1150-1158. 537 
96. Saiag P, Pavlovic M, Lebreton C et al. Value of nuclear-magnetic-resonance imaging in severe infectious cellulitis – 538 
prospective-study. La Revue de médecine interne 1992; 13:S337-S337.  539 
97. Schmid MR, Kossmann T, Duewell S. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J 540 
Roentgenol 1998; 170(3):615-620. 541 
98. Simonart T, Nakafusa J, Narisawa Y. The importance of serum creatine phosphokinase level in the early diagnosis 542 
and microbiological evaluation of necrotizing fasciitis. J Eur Acad Dermatol Venereol 2004; 18:687-90. 543 
99. Simonart T, Simonart JM, Derdelinckx I et al. Value of standard laboratory tests for the early recognition of group A 544 
beta-hemolytic streptococcal necrotizing fasciitis. Clin Infect Dis 2001; 32:E9-E12. 545 
100. Smirnova MN, Cherkasov VL, Semina NA. Antibodies to streptococcus allergen and intradermal tests in erysipelas. 546 
Zh Mikrobiol Epidemiol Immunobiol 1971; 48(10):75-80. 547 
101. Stemmer R. Diagnosis and complications of edema of the lower limbs. [French]. Phlebologie 1988; 41:355-8. 548 
102. Sullivan JA, Vasileff T, Leonard JC. An evaluation of nuclear scanning in orthopaedic infections. J Pediatr Orthop 1981; 549 
1:73-9. 550 
103. Sullivan T, De Barra E. Diagnosis and management of cellulitis. Clin Med 2018; 18:160-3. 551 
104. Sverdrup B, Blombäck M, Borglund E et al. Blood coagulation and fibrinolytic systems in patients with erysipelas and 552 
necrotizing fasciitis. Scand J Infect Dis 1981; 13(1):29-36. 553 
105. Teo ELH, Strouse PJ, Chhem RK. Musculoskeletal ultrasonography in children. Can Assoc Radiol J 2002; 53:14-21. 554 
106. Unal SN, Birinci H, Baktiroglu S et al. Comparison of Tc-99m methylene diphosphonate, Tc-99m human immune 555 
globulin, and Tc-99m-labeled white blood cell scintigraphy in the diabetic foot. Clin Nucl Med 2001; 26:1016-21. 556 
107. Wang TL, Hung CR. Role of tissue oxygen saturation monitoring in diagnosing necrotizing fasciitis of the lower limbs. 557 
Ann Emerg Med 2004; 44:222-8. 558 
108. Wellmann G, Heuner F. [Relation between serologically detected antibodies & immunity in erysipelas]. Zentralblatt fur 559 
Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene - 1 - Abt - Medizinisch-Hygienische Bakteriologie, 560 
Virusforschung und Parasitologie - Originale 1959; 175:373-87. 561 
109. Wong CH, Khin LW, Heng KS et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: A tool for 562 
distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004; 32:1535-41. 563 
110. Levell NW, CG; Garioch, JJ. Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared 564 
care between primary and secondary care. Br J Dermatol 2011; 164:1326-8. 565 
23 
 
Page 23 
 
 566 
 567 
 568 
 569 
 570 
 571 
 572 
 573 
 574 
 575 
 576 
 577 
 578 
 579 
 580 
 581 
 582 
 583 
 584 
 585 
 586 
 587 
 588 
 589 
 590 
 591 
Table 1: Search terms used in each database 592 
Database Search terms  
OVID 
MEDLINE  
1. diagnos$.mp. 2. differentiat$.mp. 3. discriminat$.mp. 4. determinin$.mp. 5. confirmat$.mp. 6. 
ascertainment.mp. 7. detect$.mp. 8. characteris$.mp. 9. characteriz$.mp. 10. identification.mp. 11. identify.mp. 
12. exp diagnosis/ 13. exp diagnostic imaging/ 14. or/1-13 15. criteria.mp. 16. criterion.mp. 17. classification.mp. 
18. clinical feature.mp. 19. clinical features.mp. 20. test$.mp. 21. tool$.mp. 22. imag$.mp. 23. assay$.mp. 24. 
accura$.mp. 25. validat$.mp. 26. exp reproducibility of results/ 27. reproducibility.mp. 28. exp validation studies/ 
29. exp validation studies as topic/ 30. exp sensitivity and specificity/ 31. sensitivity.mp. 32. specificity.mp. 33. 
exp predictive value of tests/ 34. predictive.mp. 35. or/15-34 36. and/14 and 35 37. exp diagnostic test, routine/ 
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38. diagnostic feature.mp. 39. diagnostic features.mp. 40. exp biomarkers/ 41. biomarker$.mp. 42. marker$.mp. 
43. or/37-42 44. or/36 or 43 45. exp cellulitis/ 46. cellulitis.mp. 47. exp erysipelas/ 48. erysipelas.mp. 49. or/45-
48 50. and/44 and 49 
OVID 
EMBASE 
1. diagnos$.mp. 2. differentiat$.mp. 3. discriminat$.mp. 4. determinin$.mp. 5. confirmat$.mp. 6. 
ascertainment.mp. 7. detect$.mp. 8. characteris$.mp. 9. characteriz$.mp. 10. identification.mp. 11. identify.mp. 
12. exp diagnosis/ 13. exp diagnostic imaging/ 14. or/1-13 15. criteria.mp. 16. criterion.mp. 17. classification.mp. 
18. clinical feature.mp. 19. clinical features.mp. 20. test$.mp. 21. tool$.mp. 22. imag$.mp. 23. exp assay/ 24. 
accura*.mp. 25. exp reproducibility/  26. reproducibility.mp. 27. exp validation study/ 28. validation studies as 
topic.mp. 29. validat*.mp. 30. exp ’’sensitivity and specificity’’/ 31. sensitivity.mp. 32. specificity.mp. 33. exp 
predictive value/ 34. predictive.mp. 35. or/15-34 36. and/14 and 35 37. exp diagnostic test 38. diagnostic 
feature.mp. 39. diagnostic features.mp. 40. exp biological marker/ 41. biomarker$.mp. 42. exp marker/ 43. 
marker$.mp. 44. or/37-43  45. or/36 or 44  46. exp cellulitis/ 47. cellulitis.mp. 48. exp erysipelas/ 49. 
erysipelas.mp. 50. or/46-49 51. and/45 and 50 
Cochrane 
Database Of 
Systematic 
Reviews  
 
1.diagnos*   2. differentiat*  3. discriminat*  4. determinin*   5. confirmat*  6. “ascertainment”  7. detect*  8. 
characteris*  9. characteriz* 10. “identification”  11. “identify” 12. MeSH descriptor: [Diagnosis] explode all trees    
13. MeSH descriptor: [Diagnostic Imaging] explode all trees  14. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or 
#9 or #10 or #11 or #12 or #13  15. “criteria”   16. “criterion”  17. MeSH descriptor: [Classification] explode all 
trees   18. “classification”  19. “clinical feature”  20. “clinical features”  21. test*  22. tool*  23. imag*  24. “assay”  
25. accura*  26. MeSH descriptor: [Reproducibility of Results] explode all trees 27. “reproducibility”  28. MeSH 
descriptor: [Validation Studies as Topic] explode all trees   29. “validation studies”  30. valid*   31. MeSH 
descriptor: [Sensitivity and Specificity] explode all trees  32. “sensitivity”  33. “specificity”  34. “predictive”   35.  
#15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or 
#31 or #32 or #33 or #34   36.  #14 and #35  37. MeSH descriptor: [Diagnostic Tests, Routine] explode all trees 
38. “diagnostic feature”  39. “diagnostic features”  40. MeSH descriptor: [Biomarkers] explode all trees   41. 
biomarker*  42. marker*   43. #37 or #38 or #39 or #40 or #41 or#42    44. #36 or #43  45. MeSH descriptor: 
[Cellulitis] explode all trees  46. “cellulitis” 47. MeSH descriptor: [Erysipelas] explode all trees   48. “erysipelas”    
49. #45 or #46 or #47 or #48  50. #44 and #49 
Web of 
Science 
Core 
Collection  
 
1.TS = diagnos*  2. TS = differentiat*  3. TS = discriminat*  4. TS = determinin* 5. TS = confirmat*  6. TS = 
ascertainment  7. TS = detect*  8. TS = characteris*  9. TS = characteriz*    10. TS = identification 11. TS = 
identify   12. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11  13. TS = criterion  14. TS = 
classification 15. TS = “clinical feature”   16. TS = “clinical features”   17. TS = test* 18. TS = tool*  19. TS = 
imag*   20. TS = assay   21. TS = accura*   22. TS = reproducibility   23. TS = valid*   24. TS = “validation 
studies”  25. TS = sensitivity   26. TS = specificity   27. TS = predictive  28. #13 or #14 or #15 or #16 or#17 
or#18 or#19 or #20 or #21 or #22 or#23 or #24 or #25 or #26 or #27  29. #12 and #28  30. TS = "diagnostic 
features"  31. TS = "diagnostic feature"  32. TS = biomarker*  33. TS = marker*   34. #30 or #31 or #32 or #33  
35. #29 or #34  36. TS = cellulitis  37. TS = erysipelas 38. #36 or #37  39. #35 and #38 
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Table 2: Characteristics of the eight included studies  601 
Author, 
year 
Country, 
setting  
Years 
of 
study 
Study 
type 
Diagnoses 
explored in 
the study 
Funding 
source  
Number of 
patient 
analysed  
Mean age 
of 
cellulitis 
patients 
(years) 
Number of 
male 
cellulitis 
patients 
(%) 
Index Test Reference 
test for 
cellulitis 
Timeframe 
for follow 
up 
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 602 
LRINEC = The Laboratory Risk Indicator for Necrotizing Fasciitis          CK = creatine kinase     PCT = procalcitonin     ESR=erythrocyte sedimentation rate   WBC = white cell 603 
count      DNI = delta neutrophil index ALT-70 = asymmetry, leucocytosis, tachycardia, age >70  CRP= C - reactive protein  DVT= deep vein thrombosis      ED = 604 
emergency department    CT = computed tomography  605 
 606 
Table 3: Risk of bias assessment using the QUADAS-2 diagnostic accuracy critical appraisal tool showing risk of bias for each 607 
domain for individual studies 608 
Raff et 
al, 2017 
18 
USA, 
emergency 
department 
(single 
centre) 
2010-
2012 
Cross 
sectional 
Cellulitis and 
pseudocellulitis 
None stated  259 – 180 
cellulitis and 
79 with 
pseudo 
cellulitis  
63 78 (43%) ALT-70 Clinical 
diagnosis 
by ED 
physician 
or 
admitting 
team 
30 days 
post 
discharge  
Fleischer 
et al, 
2009 13 
USA, 
podiatric 
medicine, 
(single 
centre)  
2002-
2006 
 
Case 
control   
Osteomyelitis 
and cellulitis  
 
None stated  54 – 20 
cellulitis and 
34 
osteomyelitis  
62 (whole 
population) 
44 (81%) 
(whole 
population) 
30 clinical and 
laboratory 
characteristics 
Bone 
specimen 
and 
technetium 
scan 
(unclear 
who made 
the 
diagnosis) 
No follow 
up  
Kato et 
al, 2017 
14 
Japan, 
department 
of 
dermatology 
(single 
centre) 
2010-
2014 
Case 
control   
Necrotising 
fasciitis and 
cellulitis 
None stated 18 – 16 
cellulitis, 2 
necrotising 
fasciitis  
Not 
available 
for cellulitis 
patients   
Not 
available  
for cellulitis 
patients   
LRINEC 
CK 
PCT  
Clinical 
diagnosis 
(unclear 
who made 
the 
diagnosis)  
No follow 
up 
Malabu 
et al, 
2007 15 
Saudi Arabia, 
department 
of medicine 
(single 
centre) 
2005 Case 
control  
Osteomyelitis 
and cellulitis 
None stated 43 – 21 with 
cellulitis and 
22 with 
osteomyelitis  
56 12 (57%) ESR 
Haematocrit 
Haemoglobin 
Platelet count 
Red cell width 
WBC  
Clinical 
diagnosis 
(unclear 
who made 
the 
diagnosis) 
No follow 
up 
Pyo et al 
2017 16 
South Korea, 
division of 
rheumatology 
(single 
centre) 
2010-
2015 
Case 
control  
Gout and 
cellulitis 
Korean 
health 
industry 
development 
institute 
367 – 184 
with acute 
gout and 183 
with cellulitis  
61 126 (69%) DNI Clinical 
diagnosis 
(unclear 
who made 
the 
diagnosis)  
No follow 
up 
Rabuka 
et al, 
2003 17 
Canada, 
emergency 
department 
(single 
centre) 
1995-
1998 
Cohort   DVT and 
cellulitis  
None stated  109 – 19 
DVT, 72 
cellulitis, 18 
other   
71 (for 
cellulitis/ 
DVT 
patients) 
37 (41%) Duplex 
ultrasound 
scan 
Clinical 
diagnosis 
by ED 
physician  
No follow 
up 
Rast et 
al, 2015 
19 
Switzerland,  
emergency 
department 
(single 
centre)   
2013-
2014 
Case 
control  
DVT and 
erysipelas  
Goldschmidt 
Jacobson 
Foundation, 
The Swiss 
National 
Science 
Foundation, 
The 
Kantonsspital 
Aarau 
48 – 31 
erysipelas 
and 17 with 
DVT  
31 18 (58%) PCT 
CRP 
WBC 
Clinical 
diagnosis 
by treating  
physician 
30-day 
telephone 
follow up 
Shin et 
al, 2013 
20 
South Korea, 
department 
of radiology 
(single 
centre) 
2006-
2010 
Case 
control  
Lymphoedema, 
cellulitis and 
generalised 
oedema  
None stated  44 – 11 with 
cellulitis, 19 
with 
lymphedema 
and 14 with 
generalised 
oedema  
63  5 (45%) CT scan  Clinical 
diagnosis 
(unclear 
who made 
the 
diagnosis) 
No follow 
up 
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 Risk of bias Concerns regarding applicability  
Study  Patient 
selection 
Index test Reference 
standard 
Patient 
flow and 
timing  
Patient 
selection 
Index test Reference 
standard 
Fleischer et 
al 13 
  ?      ? 
Kato et al 14   ? ?    ? 
Malabu et al 
15 
  ? ?     ? 
Pyo et al 16   ? ? ?  ? 
Rabuka et al 
17 
   ?   ? 
Raff et al 18   ? ? ?  ? 
Rast et al 19    ? ? ?  ? 
Shin et al 20   ? ?   ? 
      = high risk of bias ? = unclear risk of bias              = low risk of bias 609 
 610 
 611 
 612 
 613 
 614 
 615 
 616 
 617 
 618 
 619 
 620 
